James Emmett Young - Jan 6, 2025 Form 3 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role: Chief Financial Officer
Signature: /s/ James Emmett Young
Stock symbol: TLSI
Transactions as of: Jan 6, 2025
Transactions value $: $0
Form type: 3
Date filed: 1/15/2025, 05:47 PM
Next filing: Jan 29, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TLSI	Common Stock						9.23K	Jan 6, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TLSI	Employee Stock Option (right to buy)							Jan 6, 2025	Common Stock	43K	$4.95	Direct	F2
holding	TLSI	Employee Stock Option (right to buy)							Jan 6, 2025	Common Stock	12K	$9.50	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes grant of Restricted Stock Units for 6,000 shares (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest in equal annual installments beginning on February 12, 2024 and will become fully vested on February 12, 2028.
F2	One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of August 28, 2023, and 1/36th of the remaining shares shall vest equally each month thereafter on the same day of the month as the vesting commencement date.
F3	One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of February 12, 2024, and 1/36th of the remaining shares shall vest equally each month thereafter on the same day of the month as the vesting commencement date.